GB0017952D0 - Treatment of dyskinesia - Google Patents

Treatment of dyskinesia

Info

Publication number
GB0017952D0
GB0017952D0 GBGB0017952.3A GB0017952A GB0017952D0 GB 0017952 D0 GB0017952 D0 GB 0017952D0 GB 0017952 A GB0017952 A GB 0017952A GB 0017952 D0 GB0017952 D0 GB 0017952D0
Authority
GB
United Kingdom
Prior art keywords
dyskinesia
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0017952.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Victoria University of Manchester
University of Manchester
Original Assignee
Victoria University of Manchester
University of Manchester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Victoria University of Manchester, University of Manchester filed Critical Victoria University of Manchester
Priority to GBGB0017952.3A priority Critical patent/GB0017952D0/en
Publication of GB0017952D0 publication Critical patent/GB0017952D0/en
Priority to PCT/GB2001/003265 priority patent/WO2002007766A2/en
Priority to AU2001272650A priority patent/AU2001272650A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0017952.3A 2000-07-22 2000-07-22 Treatment of dyskinesia Ceased GB0017952D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0017952.3A GB0017952D0 (en) 2000-07-22 2000-07-22 Treatment of dyskinesia
PCT/GB2001/003265 WO2002007766A2 (en) 2000-07-22 2001-07-20 Use of d5-dopamine receptor agonists in the manufacture of a medicament for the treatment of dyskinesia
AU2001272650A AU2001272650A1 (en) 2000-07-22 2001-07-20 Use of d5-dopamine receptor agonists in the manufacture of a medicament for the treatment of dyskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0017952.3A GB0017952D0 (en) 2000-07-22 2000-07-22 Treatment of dyskinesia

Publications (1)

Publication Number Publication Date
GB0017952D0 true GB0017952D0 (en) 2000-09-13

Family

ID=9896103

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0017952.3A Ceased GB0017952D0 (en) 2000-07-22 2000-07-22 Treatment of dyskinesia

Country Status (3)

Country Link
AU (1) AU2001272650A1 (en)
GB (1) GB0017952D0 (en)
WO (1) WO2002007766A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100431431B1 (en) * 2001-04-25 2004-05-14 한미약품 주식회사 Clathrate of azithromycin hydrate with 1,2-propyleneglycol, methods for the manufacture thereof, and pharmaceutical compositions thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478934A (en) * 1994-11-23 1995-12-26 Yuan; Jun Certain 1-substituted aminomethyl imidazole and pyrrole derivatives: novel dopamine receptor subtype specific ligands
US5773616A (en) * 1995-02-15 1998-06-30 Neurogen Corporation Certain bridged 4-phenyl-2-aminomethylimidazoles; new dopamine receptor subtype specific ligands
DK0866691T4 (en) * 1995-11-06 2005-06-06 Somerset Pharmaceuticals Inc Medications for sublingual and buccal administration of selegiline
BR9811557A (en) * 1997-08-15 2000-08-22 Pfizer Prod Inc Derivatives of 2-) 4-aryl or heteroaryl-piperazin-1-ylmethyl) -1h-indole
IL125950A0 (en) * 1997-09-05 1999-04-11 Pfizer Prod Inc Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy

Also Published As

Publication number Publication date
WO2002007766A8 (en) 2002-04-11
WO2002007766A3 (en) 2002-07-18
WO2002007766A2 (en) 2002-01-31
AU2001272650A1 (en) 2002-02-05

Similar Documents

Publication Publication Date Title
GB0028264D0 (en) Well treatment
GB0014969D0 (en) Novel method of treatment
GB0028269D0 (en) Well treatment
AU5464601A (en) Treatment of scale
PL362855A1 (en) Improved treatment
EG25829A (en) Novel treatment
GB0030845D0 (en) Novel treatment
GB0011186D0 (en) Modification of bacteria
AU5000001A (en) Treatment of vitiligo
HRP20020729A2 (en) Treatment of psoriasis
GB0124124D0 (en) Methods of treatment
AU9402401A (en) Treatment of cancers
GB0008921D0 (en) Method of treatment
GB0026015D0 (en) Cancer treatment
CA91213S (en) Rollator
GB0014356D0 (en) Treatment of multiple sclerosis
GB0017952D0 (en) Treatment of dyskinesia
EP1303281A4 (en) Methods of treatment
GB0007194D0 (en) Treatment of dyskinesia
GB0031321D0 (en) Treatment
GB0029125D0 (en) Novel treatment
GB0127006D0 (en) Treatment of moccasion seam
GB0014904D0 (en) Methods of treatment
GB0013928D0 (en) Methods of treatment
GB0019728D0 (en) Novel treatment

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)